ASTELLAS PHARMA, INC. (ALPMY)
Clinical trial NCT06792435 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2025-12-31 → 2027-06-30 3. primary completion date: 2025-06-30 → 2026-12-30 4. collaborators added: Evopoint Biosciences Inc.
📉 **NEGATIVE** • Low confidence analysis (51%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (45%) **Content type:** Clinical